Northwestern Medicine’s Pioneering Efforts in Treating Long COVID-19
Northwestern Medicine’s Comprehensive COVID-19 Center, co-directed by Dr. Igor J. Koralnik, chief of Neuroinfectious Diseases and Global Neurology, has been at the forefront of treating and understanding Long COVID-19. The center has provided personalized care to nearly 4,000 patients, offering insights into the multi-system nature of the disease.
HCN Medical Memo
The work being done at Northwestern Medicine underscores the importance of continued research and treatment for Long COVID-19. As healthcare professionals, it is crucial to stay informed about these developments to provide the best care for our patients.
- Northwestern Medicine established one of the first comprehensive centers for treating Long COVID-19.
- Long COVID-19 occurs in approximately a third of COVID-19 survivors.
- The center has treated nearly 4,000 patients via 42 clinicians, providing a personalized approach based on their initial symptoms.
- Long COVID-19 is not a one-size-fits-all disease; it requires different approaches for patients who had severe COVID-19 pneumonia and those who had mild cases but developed lingering problems.
Long COVID-19 is now the third-leading neurologic disorder in the United States.
- A recent study from the center surveyed more than 1,800 patients and found that 49% came to neurology, 25% came to pulmonology, and 12% came to cardiology.
- The most common neurologic symptoms reported are brain fog, headache, muscle pain, fatigue, and exercise intolerance.
- Among those who were not hospitalized for their acute COVID-19 presentation, the predominant population was female in their 40s.
Latest on COVID-19